Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
about
An EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancerErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner.Positive and negative regulation of endogenous genes by designed transcription factorsErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinasesSecretion of novel SEL1L endogenous variants is promoted by ER stress/UPR via endosomes and shed vesicles in human cancer cellsSpheroids of HER2-Positive Breast Adenocarcinoma for Studying Anticancer Immunotoxins In Vitro.Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins.Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer.The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma.RETRACTED: 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity.HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ.Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growthComparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation.Effects of retinoic acid and fenretinide on the c-erbB-2 expression, growth and cisplatin sensitivity of breast cancer cellsNeu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.Epidermal growth factor receptor, but not c-erbB-2, activation prevents lactogenic hormone induction of the beta-casein gene in mouse mammary epithelial cells.Phosphoinositide 3-kinase targeting by the beta galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death.ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective.Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling.Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines.Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.Fluorescent IgG fusion proteins made in E. coliOestrogen and epidermal growth factor down-regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms.Comparison of two quantitative polymerase chain reaction methods for detecting HER2/neu amplification.Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.Replacement of N-terminal portions of TGF-alpha with corresponding heregulin sequences affects ligand-induced receptor signaling and intoxication of tumor cells by chimeric growth-factor toxins.
P2860
Q24297853-4A592541-5DD9-45BB-83A9-02DEEED9F712Q24522643-27DC7608-CBCF-49A3-8E85-276DBC292646Q24649843-72C5D89D-AA2D-428F-97B8-022AE1C8AA4BQ28198475-D8570B63-D2AF-43F6-9A43-186575A900E1Q28477193-301E1E44-3988-4060-BEF8-31CABBC26831Q33607808-C6814CB3-DDBF-457E-B48E-1128399C140FQ33820233-53F33CF1-B08E-46CA-BA3C-E6BB74FFF5D7Q33886341-3BA7FA49-FEE5-437F-A33F-EBCA598E44C8Q34546374-0C7A8168-A6DD-4308-AF97-165E591C0C2DQ34548277-BA02CC1F-CA14-428F-8827-61A6AAAFD9A9Q34725896-36AB7263-5201-4D92-B0FD-C54E94575871Q35107736-A5C731DE-07E5-4191-95EA-1A2AED8CFAEEQ35899068-1029AE9F-FC2C-4CB1-85FE-4F128BFBD7EFQ35977584-439FCF7F-6E22-43CC-B5BB-F72E5E2117D3Q36008206-3DFF9BD7-C806-4CBD-8F7F-E6F29EBB401EQ36114834-CBF7DCCC-0AF4-4B05-943A-BB2E6A3EFB6BQ36556065-5E0568B1-CB72-4EA4-92BB-A00CD666127EQ36719220-8FAC1B54-DDBE-4201-977D-5F6B87AE437BQ37205526-899B33CD-CA1A-477F-B063-9A95751B94FBQ37970020-CC55EC01-4303-4493-BADD-39C8CA263AFEQ40015717-61FEE84D-1A44-4494-8154-FA7622492432Q40554269-C83BFB32-5C72-4DC4-8503-3242AFBA2356Q40786697-A211077F-1C59-43EE-9EDD-561F2B106712Q40873102-F91EAEAA-1C98-4487-91D5-A91DBFFD6B97Q41216128-4B789612-5202-4877-A5E0-B508FB5F45BCQ42147350-7D1D92BE-8C19-4644-B650-DF6DCD65868EQ42590519-312201E6-3680-48FB-ABCB-7A545BB2FF35Q42718689-63656A79-0365-43B6-8432-FFA1EA468958Q43780922-8C6848ED-BF8E-4746-B304-0EF133B9CAF6Q43844110-A6E8DCB9-7F81-4962-A649-DC59F05A9798
P2860
Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
@en
Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
@nl
type
label
Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
@en
Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
@nl
prefLabel
Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
@en
Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
@nl
P2093
P356
P1476
Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
@en
P2093
P2860
P304
P356
10.1002/JCB.240390208
P577
1989-02-01T00:00:00Z